-
Increased commitment to responsible antibiotic use in animals in EU
Increased commitment to responsible antibiotic use in animals in EU
-
Increased commitment to responsible antibiotic use in animals in EU
Increased commitment to responsible antibiotic use in animals in EU
A report published by EMA shows that European countries continue to reduce the use of antibiotics in animals. The overall sales of veterinary antibiotics across Europe dropped by more than 32% between 2011 and 2017.
-
European Network of Paediatric Research at EMA elects new chair
European Network of Paediatric Research at EMA elects new chair
-
European Network of Paediatric Research at EMA elects new chair
European Network of Paediatric Research at EMA elects new chair
The European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) has elected Pirkko Lepola of the Finnish Investigators Network for Pediatric Medicines (FinPedMed) as the new chair of its Coordinating Group for the next three years.
-
EMA advises companies on steps to take to avoid nitrosamines in human medicines
EMA advises companies on steps to take to avoid nitrosamines in human medicines
-
EMA advises companies on steps to take to avoid nitrosamines in human medicines
EMA advises companies on steps to take to avoid nitrosamines in human medicines
EMA’s human medicines committee (CHMP) is requesting as a matter of precaution that marketing authorisation holders for human medicines containing chemically synthesised active substances review their medicines for the possible presence of nitrosamines and test all products at risk.
-
Updated guidance for industry on preparing for Brexit
Updated guidance for industry on preparing for Brexit
-
Updated guidance for industry on preparing for Brexit
Updated guidance for industry on preparing for Brexit
EMA and the European Commission provide additional information on exemptions for batch testing to help pharmaceutical companies prepare for the UK’s withdrawal from the EU.
